rss feeds Last update More than a quarter of emergency contraceptives in Peru falsified ..., Apr 18, 2014

Medications news

Study recalculates costs of combination vaccines

One of the most popular vaccine brands for children may not be the most cost-effective choice. And doctors may be overlooking some cost factors when choosing vaccines, driving the market toward what is actually a more expensive ...

Apr 17, 2014
popularity 2 / 5 (1) | comments 0

Drug watchdog urges vigilance in cancer drug theft

Europe's medicine watchdog urged doctors Thursday to be vigilant in administering the cancer drug Herceptin, vials of which had been stolen in Italy and tampered with before being sold back into the supply chain.

Apr 17, 2014
popularity not rated yet | comments 0

Pyridoxine-doxylamine drug safety data lacking

(Medical Xpress)—The most commonly prescribed drug for pregnant women suffering from morning sickness in their first trimester does not prevent birth defects even though drug safety data says it does, according to research ...

Apr 16, 2014
popularity not rated yet | comments 0

FDA approves new type 2 diabetes drug

(HealthDay)—Millions of Americans with type 2 diabetes have a new treatment option with the U.S. Food and Drug Administration's approval Tuesday of a once-weekly injectable drug, Tanzeum.

Apr 15, 2014
popularity 5 / 5 (1) | comments 0

Tamiflu and Relenza: How effective are they?

Tamiflu (the antiviral drug oseltamivir) shortens symptoms of influenza by half a day, but there is no good evidence to support claims that it reduces admissions to hospital or complications of influenza. This is according ...

Apr 11, 2014
popularity 5 / 5 (1) | comments 0

More News Stories

Pharma firms turn attention to hearing loss

Hearing loss affects 36 million Americans to some degree, often leaving them feeling isolated, but it has received little attention from the pharmaceutical industry—until now. Small firms have brought a handful of potential ...

US jury hits Takeda, Eli Lilly with $9B penalty (Update)

A U.S. jury ordered Japanese drugmaker Takeda Pharmaceutical Co. and its U.S. counterpart, Eli Lilly and Co., to pay $9 billion in punitive damages over a diabetes medicine linked to cancer. The drug companies said Tuesday ...

Other Spotlight Stories

Find more Medications news articles via sort by date page